1
|
Crane P, McGrady M, Shiel L, Liew D, Stewart S, Krum H, Reid C, Prior D, Campbell D, Coller J. Left Atrial Phasic Function Predicts NT-proBNP in Asymptomatic Community Patients at Risk for Heart Failure. Heart Lung Circ 2021. [DOI: 10.1016/j.hlc.2021.06.083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
2
|
Wang B, Xu T, Huang L, Hua Y, Cai Y, Ma Y, Wang K, Krum H, Scammells P, Ju S. Novel Anti-Inflammatory Agent VCP979 Treatment Improves Cardiac Function in Post-Myocardial Infarction Diabetes Mice. Heart Lung Circ 2018. [DOI: 10.1016/j.hlc.2018.06.163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
3
|
Gong F, Jelinek M, Castro J, Coller J, McGrady M, Boffa U, Shiel L, Liew D, Wolfe R, Stewart S, Owen A, Krum H, Reid C, Prior D, Campbell D. Risk Factors for Incident Heart Failure with Preserved or Reduced Ejection Fraction in a Community-Based Cohort. Heart Lung Circ 2018. [DOI: 10.1016/j.hlc.2018.06.189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
4
|
Driscoll A, Currey J, Krum H, Tonkin A. Nurse-led Titration of Angiotensin Converting Enzyme Inhibitors and Beta-Adrenergic Blocking Agents for Patients with Heart Failure with Reduced Ejection Fraction: A Meta-Analysis. Heart Lung Circ 2016. [DOI: 10.1016/j.hlc.2016.06.708] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
5
|
Chin K, Skiba M, Tonkin A, Reid C, Liew D, Krum H, Hopper I. Treatment Gap in Heart Failure with Reduced Ejection Fraction Patients: How Well are we Implementing Evidence-Based Care? Heart Lung Circ 2016. [DOI: 10.1016/j.hlc.2016.06.293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
6
|
Eikelis N, Hering D, Marusic P, Sari C, Walton A, Phillips S, Lambert E, Duval J, Krum H, Lambert G, Esler M, Schlaich M. The effect of renal denervation on endothelial function and inflammatory markers in patients with resistant hypertension. Int J Cardiol 2015; 188:96-8. [DOI: 10.1016/j.ijcard.2015.04.041] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/02/2015] [Accepted: 04/03/2015] [Indexed: 11/26/2022]
|
7
|
Hopper I, Skiba M, Tonkin A, Krum H. Aspirin withdrawal in stable heart failure patients results in no change in clinical status or quality of life. Heart Lung Circ 2015. [DOI: 10.1016/j.hlc.2015.06.203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
8
|
Owen A, Ashton E, Krum H, Reid C, Liew D, Boffa U, Stewart S, Shiel L, Wolfe R, Campbell D. Association between adequacy of long chain omega-3 intake and N-terminal pro brain natriuretic peptide (NT-proBNP) in those at risk of heart failure. Heart Lung Circ 2015. [DOI: 10.1016/j.hlc.2015.06.782] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
9
|
Wang I, Huang L, Fu P, Wang B, Bach L, Krum H. Insulin-like growth factor-1 directly affects cardiac cellular remodelling via distinct pathways. Heart Lung Circ 2015. [DOI: 10.1016/j.hlc.2015.06.159] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
10
|
Selkrig L, Andrianopoulos N, Nanayakkara S, Krum H, Dart A, Clark D, Brennan A, Shaw J, Ajani A, New G, Hiew C, Duffy S. Impact of left ventricular function on outcomes following percutaneous coronary intervention. Heart Lung Circ 2015. [DOI: 10.1016/j.hlc.2015.06.231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
11
|
Wang B, von Lueder T, Kompa A, Huang L, Webb R, Jordaan P, Atar D, Krum H. LCZ696, an angiotensin receptor neprilysin inhibitor, attenuates renal fibrosis after myocardial infarction and reduces angiotensin-II-mediated renal cellular collagen synthesis. Heart Lung Circ 2015. [DOI: 10.1016/j.hlc.2015.06.236] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
12
|
Hopper I, Skiba M, Tonkin A, Krum H. Statin withdrawal in stable heart failure patients results in no change in clinical status or quality of life. Heart Lung Circ 2015. [DOI: 10.1016/j.hlc.2015.06.256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
13
|
McBride M, Krum H, Schlaich M, Whitbourn R, Walton T, Tilden D, Gillespie J. Effectiveness of Catheter-Based Renal Denervation for Treatment Resistant Hypertension - Results of a Systematic Review and Meta-Analysis. Value Health 2014; 17:A757-A758. [PMID: 27202761 DOI: 10.1016/j.jval.2014.08.239] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- M McBride
- Medtronic Australasia Ltd, North Ryde, NSW, Australia
| | - H Krum
- Monash University, Melbourne, Australia
| | | | - R Whitbourn
- University of Melbourne, Melbourne, Australia
| | - T Walton
- Epworth Hospital, Richmond, VIC, Australia
| | - D Tilden
- THEMA Consulting Pty. Ltd., Pyrmont, Australia
| | - J Gillespie
- Medtronic Australasia Ltd, North Ryde, Australia
| |
Collapse
|
14
|
Gillespie J, Walton T, Schlaich M, Whitbourn R, Krum H, McBride M. Prevalence of Severe Treatment Resistant Hypertension and Eligibility for Catheter-Based Renal Denervation in Australia - a Preliminary Analysis. Value Health 2014; 17:A759. [PMID: 27202772 DOI: 10.1016/j.jval.2014.08.246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- J Gillespie
- Medtronic Australasia Ltd, North Ryde, Australia
| | - T Walton
- Epworth Hospital, Richmond, VIC, Australia
| | | | - R Whitbourn
- University of Melbourne, Melbourne, Australia
| | - H Krum
- Monash University, Melbourne, Australia
| | - M McBride
- Medtronic Australasia Ltd, North Ryde, NSW, Australia
| |
Collapse
|
15
|
Tilden D, McBride M, Whitbourn R, Krum H, Walton T, Gillespie J. Cost Effectiveness of Catheter-Based Renal Denervation for Treatment Resistant Hypertension - an Australian Payer Perspective. Value Health 2014; 17:A762. [PMID: 27202791 DOI: 10.1016/j.jval.2014.08.266] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- D Tilden
- THEMA Consulting Pty. Ltd., Pyrmont, Australia
| | - M McBride
- Medtronic Australasia Ltd, North Ryde, NSW, Australia
| | - R Whitbourn
- University of Melbourne, Melbourne, Australia
| | - H Krum
- Monash University, Melbourne, Australia
| | - T Walton
- Epworth Hospital, Richmond, VIC, Australia
| | - J Gillespie
- Medtronic Australasia Ltd, North Ryde, Australia
| |
Collapse
|
16
|
Eschalier R, McMurray J, Swedberg K, Veldhuisen van D, Krum H, Pocock S, Shi H, Vincent J, Rossignol P, Zannad F, Pitt B. SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE). Racionalʹnaâ farmakoterapiâ v kardiologii 2014. [DOI: 10.20996/1819-6446-2014-10-1-106-115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
17
|
Campbell DJ, McGrady M, Prior DL, Coller JM, Boffa U, Shiel L, Liew D, Wolfe R, Stewart S, Reid CM, Krum H. Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classes. Intern Med J 2013; 43:137-43. [PMID: 22909211 DOI: 10.1111/j.1445-5994.2012.02927.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2012] [Accepted: 08/28/2012] [Indexed: 01/11/2023]
Abstract
BACKGROUND A significant proportion of individuals taking antihypertensive therapies fail to achieve blood pressures <140/90 mmHg. In order to develop strategies for improved treatment of blood pressure, we examined the association of blood pressure control with antihypertensive therapies and clinical and lifestyle factors in a cohort of adults at increased cardiovascular risk. METHODS A cross-sectional study of 3994 adults from Melbourne and Shepparton, Australia enrolled in the SCReening Evaluation of the Evolution of New Heart Failure (SCREEN-HF) study. Inclusion criteria were age ≥60 years with one or more of self-reported ischaemic or other heart disease, atrial fibrillation, cerebrovascular disease, renal impairment or treatment for hypertension or diabetes for ≥2 years. Exclusion criteria were known heart failure or cardiac abnormality on echocardiography or other imaging. The main outcome measures were the proportion of participants receiving antihypertensive therapy with blood pressures ≥140/90 mmHg and the association of blood pressure control with antihypertensive therapies and clinical and lifestyle factors. RESULTS Of 3623 participants (1975 men and 1648 women) receiving antihypertensive therapy, 1867 (52%) had blood pressures ≥140/90 mmHg. Of these 1867 participants, 1483 (79%) were receiving only one or two antihypertensive drug classes. Blood pressures ≥140/90 mmHg were associated with increased age, male sex, waist circumference and log amino-terminal-pro-B-type natriuretic peptide levels. CONCLUSIONS Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classes. Prescribing additional antihypertensive drug classes and lifestyle modification may improve blood pressure control in this population of individuals at increased cardiovascular risk.
Collapse
Affiliation(s)
- D J Campbell
- St Vincent's Institute of Medical Research, Melbourne, Victoria, Australia.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Krum H, Schlaich M, Esler M, Mahfoud F, Boehm M. Renal artery denervation via catheter-based delivery of low-power radiofrequency energy provides safe and durable blood pressure reduction: complete 3 year results from SYMPLICITY HTN-1. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht309.3787] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
19
|
|
20
|
Chowdhury EK, Owen A, Krum H, Wing LMH, Ryan P, Nelson MR, Reid CM. Barriers to achieving blood pressure treatment targets in elderly hypertensive individuals. J Hum Hypertens 2013; 27:545-51. [PMID: 23448846 PMCID: PMC3747330 DOI: 10.1038/jhh.2013.11] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2012] [Revised: 01/09/2013] [Accepted: 01/13/2013] [Indexed: 11/26/2022]
Abstract
High blood pressure (BP) is highly prevalent among the elderly, and even with pharmacological therapy BP is difficult to control to guideline recommended levels. Although poor compliance to therapy is associated with less BP control, little is known regarding other barriers to attaining on-treatment target BP. This study examined factors associated with achieving on-treatment target BP in 6010 hypertensive participants aged 65-84 years from the Second Australian National Blood Pressure study. Participants were followed for a median of 4.1 years, with BP monitored every 6 months. 'Target BP' was defined as a reduction of systolic/diastolic BP of at least 20/10 mm Hg and BP <160/90 mm Hg from randomization in two consecutive follow-up visits. Cox regression was used to identify factors associated with achieving target BP from a number of baseline and in-study factors. Mean BP at randomization was 168/91 mm Hg and patients had a median of 9 (range: 2-20) study visits. Target BP was achieved in 50% of patients. Demographic factors associated with achieving target BP were male gender, living in a regional area; and clinical factors included history of antihypertensive therapy, increased plasma creatinine, lower pretreatment pulse pressure and in-study use of multiple BP-lowering drugs. Those aged >80 years and seeking care from multiple doctors (hazard ratio 0.40, 95% confidence interval 0.36-0.45, P<0.001) were less likely to achieve target BP. These findings identify clinical markers that can be targeted for intervention, but also demographic factors related to service delivery, which may provide further opportunity for achieving better BP control in hypertensive elderly.
Collapse
Affiliation(s)
- E K Chowdhury
- Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
| | - A Owen
- Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
| | - H Krum
- Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
| | - L M H Wing
- Department of Clinical Pharmacology, School of Medicine, Flinders University, Adelaide, South Australia, Australia
| | - P Ryan
- Discipline of Public Health, University of Adelaide, Adelaide, South Australia, Australia
| | - M R Nelson
- Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania, Australia
| | - C M Reid
- Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
| |
Collapse
|
21
|
Campbell DJ, McGrady M, Prior DL, Coller JM, Boffa U, Shiel L, Liew D, Stewart S, Reid CM, Krum H. Author reply. Intern Med J 2013; 43:1052-3. [DOI: 10.1111/imj.12242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2013] [Accepted: 07/07/2013] [Indexed: 11/29/2022]
Affiliation(s)
- D. J. Campbell
- Department of Medicine; University of Melbourne; Melbourne Victoria Australia
- Department of Molecular Cardiology; St Vincent's Institute of Medical Research; Melbourne Victoria Australia
| | - M. McGrady
- Department of Epidemiology and Preventive Medicine; Monash University; Melbourne Victoria Australia
| | - D. L. Prior
- Department of Medicine; University of Melbourne; Melbourne Victoria Australia
- Cardiac Investigation Unit; St Vincent's Health; Melbourne Victoria Australia
| | - J. M. Coller
- Cardiac Investigation Unit; St Vincent's Health; Melbourne Victoria Australia
| | - U. Boffa
- Department of Medical Services; Bupa
| | - L. Shiel
- Department of Epidemiology and Preventive Medicine; Monash University; Melbourne Victoria Australia
| | - D. Liew
- Department of Clinical Epidemiology; University of Melbourne; Melbourne Victoria Australia
| | - S. Stewart
- Department of Preventive Cardiology; Baker IDI Heart and Diabetes Institute; Melbourne Victoria Australia
| | - C. M. Reid
- Department of Epidemiology and Preventive Medicine; Monash University; Melbourne Victoria Australia
| | - H. Krum
- Department of Epidemiology and Preventive Medicine; Monash University; Melbourne Victoria Australia
| |
Collapse
|
22
|
Lemke B, Kloppe A, Birnie D, Aonuma K, Krum H, Fun Lee KL, Gasparini M, Starling R, Gorcsan J, Martin DO. More frequent optimization by the adaptive crt algorithm in patients with higher daily activity: analysis of the adaptive crt trial. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht309.p3154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
23
|
Girerd N, Collier T, Pocock S, Krum H, Mcmurray J, Swedberg K, Van Veldhuisen D, Vincent J, Pitt B, Zannad F. Clinical benefits of Eplerenone in patients with systolic NYHA II heart failure when initiated shortly after hospital discharge. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht309.p3304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
24
|
Kompa AR, Kumfu S, Lekawanvijit S, Wang BH, Krum H. The uremic toxin adsorbent AST-120 abrogates renal injury post-MI evidenced by normalization of KIM-1 protein expression and reduced collagen turnover. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht310.p5027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
25
|
Kotecha D, Lewis A, Leeson P, Krum H, New G, Pepper J, Eccleston D, Flather M, Collins P. Peripheral arterial waveforms for the prediction of death and MI: carotid versus radial pulse wave analysis. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht310.p4996] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
26
|
Liu S, Kompa AR, Kelly D, Krum H, Wang BH. Myocardial infarction accelerates pathological cardiac remodeling and renal impairment post subtotal nephrectomy. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht310.p5031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
27
|
Watanabe M, Kompa A, Wang B, Krum H. Beneficial haemodynamic effects of renal sympathetic denervation in diabetic Ren-2 transgenic (mREN2) 27 rats. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht311.5891] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
28
|
Coller J, Campbell D, Krum H, Prior D. Early Identification of Asymptomatic Subjects at Increased Risk of Heart Failure and Cardiovascular Events: Progress and Future Directions. Heart Lung Circ 2013; 22:171-8. [DOI: 10.1016/j.hlc.2012.09.009] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2012] [Revised: 09/24/2012] [Accepted: 09/30/2012] [Indexed: 11/25/2022]
|
29
|
Clark H, Hopper I, Krum H. Does Worsening Renal Function with RAAS Inhibitors Predict Worse Clinical Outcomes? Meta-analysis of >20,000 Patients with Left Ventricular Systolic Dysfunction. Heart Lung Circ 2013. [DOI: 10.1016/j.hlc.2013.05.178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
30
|
Kompa A, von Lueder T, Wang B, Krum H. The Liver X Receptor Agonist, T0901317 Attenuates Angiotensin II-stimulated Hypertrophy and Collagen Synthesis in Cardiac Cells. Heart Lung Circ 2013. [DOI: 10.1016/j.hlc.2013.05.214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
31
|
Liu S, Kompa A, Kelly D, Krum H, Wang B. Myocardial Infarction after Subtotal Nephrectomy Accelerates Pathological Cardiac Remodelling and Renal Impairment. Heart Lung Circ 2013. [DOI: 10.1016/j.hlc.2013.05.198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
32
|
Hering D, Walton A, Lambert G, Marusic P, Lambert E, Krum H, Esler M, Schlaich M. The Effect of Renal Nerve Ablation on Blood Pressure and Sympathetic Activity One Year Post Procedure. Heart Lung Circ 2013. [DOI: 10.1016/j.hlc.2013.05.064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
33
|
Krum H, Schlaich M, Esler M. Predictors of Blood Pressure Response Following Catheter Renal Denervation: A Pooled Analysis of the Symplicity HTN-1 and HTN-2 Trials. Heart Lung Circ 2013. [DOI: 10.1016/j.hlc.2013.05.049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
34
|
Kotecha D, New G, Collins P, Krum H, Pepper J, Flather MD. 146 B-type natriuretic peptide and coronary atherosclerosis: an association dependent on central pulse pressure: Abstract 146 Figure 1. Heart 2012. [DOI: 10.1136/heartjnl-2012-301877b.146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
35
|
Peck K, Lim Y, Hopper I, Krum H. Does Drug Therapy Prevent Sudden Cardiac Death in Patients with Heart Failure Compared with Implantable Cardioverter-Defibrillator? A Meta-Analysis of Randomised Controlled Trials. Heart Lung Circ 2012. [DOI: 10.1016/j.hlc.2012.05.199] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
36
|
Liu S, Kompa A, Krum H, Kelly D, Wang B. Subtotal Nephrectomy Accelerates Pathological Cardiac Remodeling Post Myocardial Infarction: Implications for the Cardiorenal Syndrome. Heart Lung Circ 2012. [DOI: 10.1016/j.hlc.2012.05.236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
37
|
Krum H, Best M, Tonkin A, Hayward C, Hare D, Sindone A, Valenti L, Britt H, Flanagan D. Prevalence of Heart Failure and Use of Beta-Blockers in Australian General Practice. Heart Lung Circ 2012. [DOI: 10.1016/j.hlc.2012.05.225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
38
|
Liu S, Kompa A, Krum H, Kelly D, Wang B. Myocardial Infarction Accelerates Pathological Cardiac Remodeling and Renal Fibrosis Post Subtotal Nephrectomy: Implications for Cardiorenal Syndrome. Heart Lung Circ 2012. [DOI: 10.1016/j.hlc.2012.05.219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
39
|
Coller J, McGrady M, Shiel L, Reid C, Boffa U, Liew D, Stewart S, Wolfe R, Krum H, Campbell D, Prior D. Comparison of Traditional and Recent Classification Systems in the Grading of Diastolic Function in Asymptomatic Older Subjects. Heart Lung Circ 2012. [DOI: 10.1016/j.hlc.2012.05.481] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
40
|
Samuel R, Zimmet H, Hopper I, Paukovics G, Wang B, Zannettino A, Kaye D, Peter K, Bassler N, Krum H. Are Circulating Adult Stem Cell Levels Increased in Acute Decompensated Heart Failure? Heart Lung Circ 2012. [DOI: 10.1016/j.hlc.2012.05.185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
41
|
O’Brien J, Reid C, Andrianopoulos N, Ajani A, Clark D, Krum H, Loane P, Stub D, New G, Sebastian M, Brennan A, Dart A, Duffy S. Heart Rate as a Predictor of Outcome Following Percutaneous Coronary Intervention. Heart Lung Circ 2012. [DOI: 10.1016/j.hlc.2012.05.393] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
42
|
Watanabe M, See F, Kompa A, Wang B, Lekawanvijit S, Gilbert R, Connelly K, Boyle A, Kelly D, Krum H. Tranilast Reduces Pathological Cardiac Fibrosis and Improves Diastolic Function Following Kidney Dysfunction: Implication for Cardio-Renal Syndrome. Heart Lung Circ 2012. [DOI: 10.1016/j.hlc.2012.05.246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
43
|
McGrady M, Krum H, Carrington M, Stewart S, Zeitz C, Lee G, Marwick T, Haluska B, Brown A. Heart Failure, Ventricular Dysfunction and Risk Factor Prevalence in a Young Aboriginal Population: The Heart of the Heart Study. Heart Lung Circ 2012. [DOI: 10.1016/j.hlc.2012.05.746] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
44
|
Wang B, Sangaralingham S, Huang L, Krum H, Burnett J. Defective Collagen Turnover Due to Increased Tissue Inhibitor of Matrix Metalloproteinase-1 and 2 Expression with Aging is Associated with Cardiorenal Fibrosis and Dysfunction. Heart Lung Circ 2012. [DOI: 10.1016/j.hlc.2012.05.196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
45
|
Krum H, Sindone A, Adena M. Heart Failure Patient Demographics and Beta-Blocker Dose in Australian Clinical Practice. An Analysis of Medicare Australia Dispensing Data. Heart Lung Circ 2012. [DOI: 10.1016/j.hlc.2012.05.206] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
46
|
von Lueder T, Wang B, Huang L, Kompa A, Webb R, Jordan P, Krum H. Dual-acting Angiotensin Receptor-Neprilysin Inhibition Mediates Superior Anti-fibrotic and Anti-hypertrophic Effects in Cultured Cardiac Cells. Heart Lung Circ 2012. [DOI: 10.1016/j.hlc.2012.05.147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
47
|
Kotecha D, New G, Flather MD, Eccleston D, Pepper J, Krum H. Five-minute heart rate variability can predict obstructive angiographic coronary disease. Heart 2011; 98:395-401. [DOI: 10.1136/heartjnl-2011-300033] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
48
|
O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJV, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalán R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Méndez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WHW, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F, Califf RM. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011; 365:32-43. [PMID: 21732835 DOI: 10.1056/nejmoa1100171] [Citation(s) in RCA: 970] [Impact Index Per Article: 74.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
BACKGROUND Nesiritide is approved in the United States for early relief of dyspnea in patients with acute heart failure. Previous meta-analyses have raised questions regarding renal toxicity and the mortality associated with this agent. METHODS We randomly assigned 7141 patients who were hospitalized with acute heart failure to receive either nesiritide or placebo for 24 to 168 hours in addition to standard care. Coprimary end points were the change in dyspnea at 6 and 24 hours, as measured on a 7-point Likert scale, and the composite end point of rehospitalization for heart failure or death within 30 days. RESULTS Patients randomly assigned to nesiritide, as compared with those assigned to placebo, more frequently reported markedly or moderately improved dyspnea at 6 hours (44.5% vs. 42.1%, P=0.03) and 24 hours (68.2% vs. 66.1%, P=0.007), but the prespecified level for significance (P≤0.005 for both assessments or P≤0.0025 for either) was not met. The rate of rehospitalization for heart failure or death from any cause within 30 days was 9.4% in the nesiritide group versus 10.1% in the placebo group (absolute difference, -0.7 percentage points; 95% confidence interval [CI], -2.1 to 0.7; P=0.31). There were no significant differences in rates of death from any cause at 30 days (3.6% with nesiritide vs. 4.0% with placebo; absolute difference, -0.4 percentage points; 95% CI, -1.3 to 0.5) or rates of worsening renal function, defined by more than a 25% decrease in the estimated glomerular filtration rate (31.4% vs. 29.5%; odds ratio, 1.09; 95% CI, 0.98 to 1.21; P=0.11). CONCLUSIONS Nesiritide was not associated with an increase or a decrease in the rate of death and rehospitalization and had a small, nonsignificant effect on dyspnea when used in combination with other therapies. It was not associated with a worsening of renal function, but it was associated with an increase in rates of hypotension. On the basis of these results, nesiritide cannot be recommended for routine use in the broad population of patients with acute heart failure. (Funded by Scios; ClinicalTrials.gov number, NCT00475852.).
Collapse
Affiliation(s)
- C M O'Connor
- Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27710, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Connelly KA, Advani A, Advani S, Zhang Y, Thai K, Thomas S, Krum H, Kelly DJ, Gilbert RE. Combination angiotensin converting enzyme and direct renin inhibition in heart failure following experimental myocardial infarction. Cardiovasc Ther 2011; 31:84-91. [PMID: 21884026 DOI: 10.1111/j.1755-5922.2011.00292.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
AIMS Diminishing the activity of the renin-angiotensin system (RAS) plays a pivotal role in the treatment of heart failure. In addition to angiotensin converting enzyme (ACE) inhibitors and angiotensin-receptor blockers, direct renin inhibition has emerged as a potential adjunctive treatment to conventional RAS blockade. We sought to determine the effectiveness of this strategy after myocardial infarction (MI) in the setting of preexisting hypertension, a common premorbid condition in patients with ischemic heart disease. METHODS AND RESULTS Ten-week-old female heterozygous hypertensive (mRen-2)27 transgenic rats (Ren-2), were randomized to one of five groups (n = 8 per group); sham, MI, MI + aliskiren, MI + lisinopril and MI + combination lisinopril and aliskiren. Cardiac function was assessed by echocardiography and in vivo cardiac catheterization. Untreated MI animals developed heart failure with hypotension, dilation, reduced ejection fraction (EF), and raised left ventricular end-diastolic pressure (LVEDP). Treatment with single agent treatment had only modest effect on cardiac function though combination therapy was associated with significant improvements in EF and LVEDP when compared to untreated MI animals (P < 0.05). Histologic analysis demonstrated increase extracellular matrix deposition and cardiomyocyte hypertrophy in the noninfarct region of all MI groups when compared with sham operated animals (P < 0.05) that was reduced by ACE inhibitor monotherapy and combination treatment but not by aliskiren alone. CONCLUSION In a hypertensive rat model that underwent experimental MI, EF, and LVEDP, key functional indices of heart failure, were improved by treatment with combination ACE and direct renin inhibition when compared with either agent used alone.
Collapse
Affiliation(s)
- K A Connelly
- Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital and University of Toronto, Toronto, Canada
| | | | | | | | | | | | | | | | | |
Collapse
|
50
|
|